机构

• 上海药物研究所 [72]
• 合肥物质科学研究院 [25]
• 上海生物化学与细胞... [12]
• 化学研究所 [7]
• 金属研究所 [6]
• 高能物理研究所 [6]
• 更多

采集方式

• OAI收割 [152]
• iSwitch采集 [9]

内容类型

• 期刊论文 [149]
• 会议论文 [7]
• 学位论文 [5]

发表日期

• 2025 [2]
• 2024 [5]
• 2023 [2]
• 2022 [12]
• 2021 [11]
• 2020 [13]
• 更多

学科主题

• Cell Biolo... [6]
• Oncology; ... [3]
• Biochemist... [2]
• Oncology [2]
• Biochemist... [1]
• Biochemist... [1]
• 更多

筛选

浏览/检索结果: 共161条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 Pharmacokinetics, mass balance, and metabolism of [14C]PLB1004, a selective and irreversible EGFR-TKI in humans 期刊论文  OAI收割 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2025, 卷号: 95, 期号: 1, 页码: 14 作者:  Liu, Donghui;  Li, Qian;  Yan, Shu;  Zhang, Xinyue;  Li, Weiqiang   |  收藏  |  浏览/下载：9/0  |  提交时间：2025/04/01 PLB1004  [C-14]PLB1004  Radioactivity  Mass balance  EGFR-TKI   REG3A secreted by peritumoral acinar cells enhances pancreatic ductal adenocarcinoma progression via activation of EGFR signaling 期刊论文  OAI收割 CELL COMMUNICATION AND SIGNALING, 2025, 卷号: 23, 期号: 1, 页码: 19 作者:  Ren, Xiaojing;  Teng, Yunfei;  Xie, Kunxin   |  收藏  |  浏览/下载：13/0  |  提交时间：2025/04/01 REG3A  Pancreatic ductal adenocarcinoma  Peritumoral acinar cell  Epidermal growth factor receptor (EGFR)  Paracrine   Integrative study of lung cancer adeno-to-squamous transition in EGFR TKI resistance identifies RAPGEF3 as a therapeutic target 期刊论文  OAI收割 NATIONAL SCIENCE REVIEW, 2024, 卷号: 11, 期号: 12, 页码: 20 作者:  Wang, Hua;  Tang, Shijie;  Wu, Qibiao;  He, Yayi;  Zhu, Weikang   |  收藏  |  浏览/下载：11/0  |  提交时间：2025/02/28 EGFR-mutant lung cancer  adeno-to-squamous transition  tyrosine kinase inhibitor resistance  transcription factor network  RAPGEF3   Design and Synthesis of Dual Galectin-3 and EGFR Inhibitors Against Liver Fibrosis 期刊论文  OAI收割 CHEMISTRY-AN ASIAN JOURNAL, 2024, 页码: 14 作者:  Liu, Shuanglin;  He, Fei;  Jin, Can;  Li, Qing;  Zhao, Guilong   |  收藏  |  浏览/下载：6/0  |  提交时间：2024/12/25 Galectin-3  EGFR  Inhibitor  Synthesis  Liver fibrosis   Targeting EGFR with molecular degraders as a promising strategy to overcome resistance to EGFR inhibitors 期刊论文  OAI收割 FUTURE MEDICINAL CHEMISTRY, 2024, 页码: 22 作者:  Wang, Qiangfeng;  Zhu, Yumeng;  Pei, Junping   |  收藏  |  浏览/下载：12/0  |  提交时间：2024/10/21 cancer  degrader  EGFR  lysosome-based degradation  PROTAC  resistance   D3EGFR: a webserver for deep learning-guided drug sensitivity prediction and drug response information retrieval for EGFR mutation-driven lung cancer 期刊论文  OAI收割 BRIEFINGS IN BIOINFORMATICS, 2024, 卷号: 25, 期号: 3, 页码: 10 作者:  Shi, Yulong;  Li, Chongwu;  Zhang, Xinben;  Peng, Cheng;  Sun, Peng   |  收藏  |  浏览/下载：42/0  |  提交时间：2024/05/07 lung cancer  EGFR mutation  drug sensitivity prediction  patient case database  deep learning   SIBP-03, a novel anti-HER3 antibody, exerts antitumor effects and synergizes with EGFR- and HER2-targeted drugs 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2024, 页码: 10 作者:  Li, Wen-jing;  Xie, Cheng-ying;  Zhu, Xi;  Tang, Jiao;  Wang, Lei   |  收藏  |  浏览/下载：56/0  |  提交时间：2024/02/19 SIBP-03  HER3  HER3-targeted therapy  neuregulin 1  EGFR  HER2   Synthesis, and biological evaluation of EGFR/HER2-NAMPT conjugates for tumor treatment 期刊论文  OAI收割 MOLECULAR DIVERSITY, 2023, 页码: 20 作者:  Ding, Mengyuan;  Shen, Qianqian;  Lu, Wei;  Zhu, Shulei   |  收藏  |  浏览/下载：100/0  |  提交时间：2023/10/17 EGFR  HER2  NAMPT  Resistance  Selectivity  Molecular docking   Discovery of HCD3514 as a potent EGFR inhibitor against C797S mutation in vitro and in vivo 期刊论文  OAI收割 JOURNAL OF CANCER, 2023, 卷号: 14, 期号: 1, 页码: 152-162 作者:  Lai, Mengzhen;  Zhang, Tao;  Chen, Hao;  Song, Peiran;  Tong, Linjiang   |  收藏  |  浏览/下载：120/0  |  提交时间：2023/04/10 fourth-generation EGFR inhibitor  EGFRC797S mutation  NSCLC  drug resistance  small molecular inhibitor   Gefitinib enhances the anti-tumor immune response against EGFR-mutated NSCLC by upregulating B7H5 expression and activating T cells via CD28H 期刊论文  OAI收割 INTERNATIONAL JOURNAL OF ONCOLOGY, 2022, 卷号: 61 作者:  Guo, Huihui;  Zhang, Xilin;  Xie, Shangzhi;  Chen, Tianwei;  Xie, Dong   |  收藏  |  浏览/下载：109/0  |  提交时间：2022/12/22 gefitinib  CD28H  NSCLC  EGFR mutation